You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Norway

Jun 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Norway with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Norway, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Norway for free:

The Consumer Health in Norway market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Norway?
  • What are the major brands in Norway?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Self-care a priority

When Norwegians become ill, doctors usually attempt to treat the core issues before prescribing medication. If the core issues include the likes of poor diet, lack of sleep or stress, the patient is likely to have a relapse with treatment. In addition, the body builds up its own natural defences to prevent illness. Overconsumption of medication can actually interfere with the body’s natural defines systems. Doctors will only prescribe medicine when absolutely necessary. Physicians usually offer advice that simplifies self-care during the illness.

Government-led health initiatives protect Norwegians from themselves

In 2010, government-led initiatives to encourage better self-care for its residents had an impact on consumer health. First the government enacted a ban on visible displays of tobacco products and accessories on 1 January 2010 to discourage smoking. Consumers are required to specifically request products for purchase. The ban had an immediate effect on sales of NRT smoking cessation aids. Smokers thinking about quitting may turn to NRT instead of cigarettes. Second, the Norwegian Directorate for Health issues annual guidelines to help Norwegians with weight management. Health conscious consumers following nutritional guidelines are likely to purchase more fruits and vegetables and cod liver oil/omega-3, but fewer single vitamins. People interested in a “quick fix” will purchase weight management products while those who become more active will consume sports nutrition. In the long-term, better eating habits and weight management are likely to reduce demand for digestive remedies.

Multinationals have a bigger role in Norway

The competitive environment for consumer healthcare in Norway is characterised by the presence of many smaller players, each within their own category. In recent years, many of the smaller companies have consolidated or been acquired by multinationals. In 2010, Weifa AS, a Norwegian company, is the only domestic company to market and produce its own brands of OTC medicines. Some of the multinationals that have recently established themselves in Norway include: Abbott Healthcare Products and Laboratoires McNeil. Several multinationals such as Nycomed Pharma AS, Novartis Norge AS, Bringwell Norway and GlaxoSmithKline AS were already present.

Shift to online retailing for OTC medicines

The role of the internet in sales of consumer health products is expected to grow during the forecast period. Health authorities are expected to liberalise the laws further and allow prescription drugs to be sold through an online system called E-Resept which is expected to become available in 2011.

Euromonitor International estimates the distribution share for non-store retailing of overall OTC medicines will grow from 0.4% in 2010 to 1.3% in 2015. The share will increase but remain a minor part of OTC sales during the forecast period. Chemists/pharmacies will remain the most important distribution channel for OTC products followed by grocery retailers throughout the forecast period. This may indicate that even though customers are able to order online, they prefer to make in-store purchases.

Moderate growth predicted during forecast period

Consumer health is expected to see a CAGR of 2% in constant value terms over the forecast period. Consumer health is a mature market with many Norwegians already consuming the products. Greater interest in marketing from both retailers and producers are likely to boost sales. In part due to the focus on staying in shape and good health, many of the products in the study are related to improving your overall being, not just getting well.

Table of Contents

Table of Contents

Consumer Health in Norway - Industry Overview

EXECUTIVE SUMMARY

Self-care a priority

Government-led health initiatives protect Norwegians from themselves

Multinationals have a bigger role in Norway

Shift to online retailing for OTC medicines

Moderate growth predicted during forecast period

KEY TRENDS AND DEVELOPMENTS

“Back to basics” common sense prevails in Norway

Government-led health initiatives

Online presence expands in consumer health

Consolidation changes competitive environment in consumer healthcare

Health claims

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

De-listing or de-reimbursement

Generics

Advertising

Packaging

Labelling

Distribution

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

Sources

  • Summary 2 Research Sources

Consumer Health in Norway - Company Profiles

Axellus AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Axellus AS: Competitive Position 2010

Midelfart Sonesson AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Midelfart Sonesson AS: Competitive Position 2010

Nycomed Pharma AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 11 Nycomed Pharma AS: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 12 Nycomed Pharma AS: Competitive Position 2010

VitaeLab AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Vitae Pro AS: Competitive Position 2010

Weifa AS in Consumer Health (Norway)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 18 Weifa AS: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 19 Weifa AS: Competitive Position 2010

Adult Mouth Care in Norway - Category Analysis

HEADLINES

TRENDS

  • Presently, concern about prevention of gum disease and treatment of mouth ailments is growing, especially as the population ages. Mouth ailments such as inflammation of gums and canker sores are a common problem in Norway. More than 90% of Norwegians experience gum inflammation at least once during their lifetime while over 50% of the population over 40-years-old experience some degree of gingivitis. Despite the number of Norwegians who experience these problems, they are usually treated by Rx medication or self-care remedies such as changes in eating habits or stress reduction. In 2010, as staying in good physical condition is a high priority for many Norwegians, good health for mouth and gums is also in focus.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline’s Corsodyl, a disinfectant available in both mouthwash and gel formats with chlorhexadine gluconate, holds the leading position in adult mouth care with a value share of 60%. Although Corsodyl has been the brand leader throughout the review period, its value share has declined since competitors such as Aftamed from VitafloScandinavia gained a foothold in adult mouth care. Corsodyl is available in both mouthwash and gel formats.

PROSPECTS

  • Concern about good health is expected to include oral hygiene to a greater degree during the forecast period, especially as the Norwegian population ages. Initiatives from Norwegian health authorities to encourage better self-care will extend to oral hygiene in the long-term. Oral hygiene is already an indirect beneficiary of many of the health initiatives launched by Norwegian health authorities such as healthy eating habits and smoking cessation.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Norway - Category Analysis

HEADLINES

TRENDS

  • Norwegian health authorities consider analgesics to be a key component in OTC healthcare but overconsumption may actually contribute to other health problems. First, Norwegian health authorities believe it is important to let the body build up its natural defences and pain relievers may actually interfere with this process. For example, fevers are considered to be part of the body’s natural defence system thus can actually contribute to strengthening the immune system. In actuality, taking analgesics for fevers may actually interfere with the body’s natural defences. Second, a debate started in 2010 has focused on whether paracetamol can cause asthma in young children. Many parents have re-evaluated how often they treat their children with analgesics.
  • Summary 20 Average Unit Price by Channel

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010, Weifa AS leads analgesics with a 75% share of value sales. Founded in 1943, Weifa has a unique position in Norway as the only domestic producer of OTC medicines in a competitive environment characterised by fierce competition among multinationals. Remaining value share is distributed among multinational players including Actavis Nordic, Nycomed Pharma, GlaxoSmithKline, Antula Healthcare and Aventis Pharma.

PROSPECTS

  • Concern about the ill effects of overconsumption are unlikely to have an impact on constant value sales during the forecast period. Analgesics is well-established in terms of brands and usage. Suppliers will use media, chemist/pharmacy staff and other channels to develop clearer distinctions about the product features of leading brands. Better educated consumers feel confident about when and how to use medicines.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Norway - Category Analysis

HEADLINES

TRENDS

  • The focus on healthy living has never been stronger in Norway. Rest and relaxation are two of the key ingredients. Health authorities encourage Norwegians to try alternative methods, the most natural, before turning to either Rx or herbal/traditional calming and sleeping medicines. Alternative techniques are based on common sense solutions such as regular bedtimes, physical activity, good eating habits and adequate daylight, which can be problematic during the long, dark winter months. If these remedies fail, Vitus Apotek sells a cd series called MusiCure to create a relaxing environment. Doctors often initially prescribe non-medicinal remedies for sleeping problems in order to avoid development of a dependence on habit-forming prescription medications. Herbal/traditional calming and sleeping remedies are considered to be non-priority remedies for rest and relaxation. Many Norwegians prefer to solve the core problems that prevent a good night’s sleep first.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cederroth leads calming and sleeping products with an 82% share of current value through its Valerina range; the best-selling brand of non-prescription sleeping remedies. Valerina comes in two varieties, Valerina Natt and Valerina Forte. The brand is an “approved herbal remedy” with marketing authorisation from the Norwegian Medicines Authority. Valerina is made from a combination of valerian root and other ingredients and sold in a variety of distribution channels including chemists/pharmacies, other healthcare specialists and some grocery retailers.

PROSPECTS

  • Few changes are expected in the competitive environment during the forecast period. Approval by the Norwegian Medicine Authority is a time-consuming process. A constant value CAGR of 2% is predicted over the forecast period, with value sales reaching NOK15 million by 2015.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2005-2010
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 26 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 27 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Norway - Category Analysis

HEADLINES

TRENDS

  • Growth in current value terms was up almost 6% in 2010. The growth was positive because of an unusually cold winter during Q1 when temperatures fell below -25C. The frigid weather drove demand for cough remedies, nasal sprays, medicated confectionery, and decongestant rubs, while current value declined for antihistamines, pharyngeal preparations and nasal drops. Cough remedies, nasal sprays, medicated confectionery and decongestant rubs accounted for a combined total turnover greater than NOK973 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • Three leading players, Novartis, Brynild Grupp

PROSPECTS

  • Demand for cough, cold and allergy (hay fever) remedies is expected to increase at a slightly slower CAGR during the forecast period than the review period. Marketing and convenience are expected to remain the key positive growth drivers in cough and cold remedies, as leading multinational manufacturers are likely to continue investing in brands such as Otrivin, Noskapin and Bisolvon.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 35 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 36 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 37 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Norway - Category Analysis

HEADLINES

TRENDS

  • Current value sales increased by 5% in 2010 to reach NOK335 million. The trend towards unhealthy lifestyles that have developed over the past 20 years are reflected in greater demand for digestive remedies. In spite of the sensible recommendations from the Norwegian Directorate of Health, Norwegians are continuing to over consume unhealthy food high in fat content such as hot dogs and sausages. As a result, surveys report one in four Norwegians is overweight, including children. Digestive problems such as indigestion and heartburn often accompany the tendency to gain weight. In 2010, most Norwegians suffer from heartburn and indigestion to some degree as well as a high incidence of constipation.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratoires McNeil, a Johnson & Johnson Inc subsidiary, leads digestive remedies with a 23% share of current value. The company has strong positions in H2 blockers, laxatives, antiflatulents and motion sickness. H2 blockers, Pepcid and Pepcid Duo, account for more than 70% of Laboratoires McNeil’s value share. Although Pepcid and Pepcid Duo are well-established brands, consumers may migrate to the newly switched proton pump inhibitors from Nycomed which provide longer lasting relief. The McNeil brands had a price advantage in 2010 as they cost 60% less than proton pump inhibitors which may help protect their position.

PROSPECTS

  • The focus on good eating habits and exercise is not enough to motivate Norwegians to give up the benefits that accompany affluent living, such as spending more time in cafés and drinking good wine. As affluence grows, Norwegians are likely to continue to eat the luxury foods which frequently cause constipation and heartburn in spite of public health initiatives.

CATEGORY DATA

  • Table 38 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 39 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 40 Digestive Remedies Company Shares by Value 2006-2010
  • Table 41 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 42 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 43 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Norway - Category Analysis

HEADLINES

TRENDS

  • Ear care remains a discretionary expenditure for a minor annoyance in 2010 despite the ever-growing interest in good health. OTC products are usually limited to ear drops to loosen ear wax. Norwegians of all ages are treated for ear aches and infections with nose drops (or spray) instead of OTC ear drops. Doctors advise their patients to use nasal drops in order to clear sinuses and alleviate ear discomfort. This is the case for Norwegians ranging in age from infancy to adulthood. More serious problems with ear infections are treated with Rx medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Orion Pharma leads ear care with a 41% share of value sales through the Revaxør brand of ear drops, used to loosen ear wax. Meda AS follows in second place with a value share of 14% for Cerusol, another brand used to loosen ear wax.

PROSPECTS

  • There was little activity in terms of new product development for ear care during the review period and this situation is unlikely to change during the forecast period. Ear care is considered a discretionary expenditure by most Norwegians for a minor annoyance. Suppliers are not likely to invest resources into developing new ear care products.

CATEGORY DATA

  • Table 44 Sales of Ear Care: Value 2005-2010
  • Table 45 Sales of Ear Care: % Value Growth 2005-2010
  • Table 46 Ear Care Company Shares by Value 2006-2010
  • Table 47 Ear Care Brand Shares by Value 2007-2010
  • Table 48 Forecast Sales of Ear Care: Value 2010-2015
  • Table 49 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Norway - Category Analysis

HEADLINES

TRENDS

  • Policies of the Norwegian health authorities seem to contribute to a lower rate of abortions in spite of a trend towards a greater number of sexually active Norwegians and a steadily declining age for sexual debut. The Norwegian Department of Public Health has registered a decrease of 2%, from 18 to 15.9 abortions per 1,000 women, for abortions performed in 2009 compared to the previous year. The number of abortions for teenagers showed the greatest decline.

SWITCHES

COMPETITIVE LANDSCAPE

  • Two companies, Nycomed Pharma and Schering Norge AS, supply OTC emergency contraception in Norway. Nycomed Pharma is the leader with an 83% share of current value in 2010 for its NorLevo brand. Schering Norge follows in second place with a 17% share for the Postinor brand. Both brands use a hormone preparation called Levonorgestrel to eliminate unwanted pregnancies.

PROSPECTS

  • Health authorities are expected to continue to encourage sexually active Norwegians to prevent unwanted pregnancies by having informed and responsible sex.

CATEGORY DATA

  • Table 50 Sales of Emergency Contraception: Value 2005-2010
  • Table 51 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 52 Emergency Contraception Company Shares by Value 2006-2010
  • Table 53 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 54 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 55 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Norway - Category Analysis

HEADLINES

TRENDS

  • In 2010, current value sales of eye care grew by 8% to reach NOK84 million, after a decline of six percentage points from the previous year. Growth was higher in the previous year because new brands of standard eye care were launched by Santen AS. Eye care has two well-developed ranges: Standard and allergy eye care. In 2010, value sales of standard eye care accounted for 46% of turnover, while allergy eye care accounted for the remainder. Most often, the purpose of standard eye care products is to replenish tear production in order to moisten the eyes or reduce redness. The purpose of eye drops for allergy care is to reduce itching, redness and dryness caused by seasonal allergic reactions.

SWITCHES

COMPETITIVE LANDSCAPE

  • Three multinational players, Novartis, Laboratoires McNeil and Actavis, led standard eye care with respective value shares of 31%, 27% and 15%. Novartis has strong positions in both allergy eye care through the Spersallerg and Zaditen brands and standard eye care through the Viscotears and Oculac brands. Laboratoires McNeil leads turnover in allergy eye care through the success of its Livostin brand while two brands of standard eye care, Simplex and Kunstig Tårevæske, underpin Actavis’ strong position in standard eye care.

PROSPECTS

  • Eye care is predicted to increase at a CAGR of 4% in constant value terms to reach NOK103 million in 2015. Standard eye care is expected to grow fastest, mainly as a result of expanded distribution channels. Optician chains are excellent distribution channels for standard eye care products. Most wearers of contact lenses use extra eye drops.

CATEGORY DATA

  • Table 56 Sales of Eye Care by Category: Value 2005-2010
  • Table 57 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 58 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 59 Eye Care Company Shares by Value 2006-2010
  • Table 60 Eye Care Brand Shares by Value 2007-2010
  • Table 61 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 62 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Norway - Category Analysis

HEADLINES

TRENDS

  • Norway follows the EU lead in enforcing strict requirements for suppliers to make health claims when marketing their brands, irrespective of their distribution channel. Since March 2010, suppliers can only make health claims about their product if the claims are supported with enough documentation to satisfy European requirements. Presently, only 28 natural remedies have obtained marketing authorisation which allows them to claim status as an “approved herbal medicine” although it does not guarantee their efficacy. Previously, herbal/traditional medicines were regulated as part of the Medicinal Regulations Act of 1999. The Norwegian Food Control Authority conducted regular inspections of marketing practices of herbal/traditional products and discovered many violations over the years.

COMPETITIVE LANDSCAPE

  • The competitive environment for herbal/traditional products is characterised by many players, all with value share less than 10%. These players differ widely in terms of their product assortment and choice of distribution channel.

PROSPECTS

  • The retail environment surrounding sales of herbal/traditional products is expected to adopt a more professional tone during the forecast period. The professional tone will be reflected in a higher level of in-store service especially in chemists/pharmacies.

CATEGORY DATA

  • Table 63 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 64 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 65 Herbal/Traditional Products Company Shares 2006-2010
  • Table 66 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 67 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 68 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Norway - Category Analysis

HEADLINES

TRENDS

  • In 2010, health authorities debate the effect diet has on the occurrence of skin problems such as acne and eczema. The Norwegian medical community follows a back to basics, common sense medical philosophy where alternative, natural methods are used to address the core problems. Many health authorities advocate appropriate nutrition as the key to treat many ailments, including skin care problems. Research conducted by a team of physicians at the University of Oslo Hospital indicates that the occurrence of acne is 40% higher among young girls who do not consume vegetables on a daily basis. Other research shows eczema is best treated through dietary modifications.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer AS leads medicated skin care with a 17% value share. The company has a strong position in antifungals where Canesten, a topical and vaginal antifungal, competes directly with Pevaryl and Daktar from McNeil. Bayer is poised for healthy growth with the introduction of a nappy rash treatment called Bepanthen in 2010 and also markets a haemorrhoid treatment called Scheriproct. Bepanthen is promoted as a gentler alternative to standard nappy rash treatments, containing zinc.

PROSPECTS

  • Marketing will play a more important role in selling medicated skin care during the forecast period than previously seen in the review period. In 2010, medicated skin is no longer limited to the clinical products previously found on pharmacy shelves. A blurring of medicated and cosmetic brands is likely to take place during the forecast period. The range of skin care brands sold in the chemist/pharmacy channel has expanded to include a variety of products to treat skin problems. Some brand ranges such as Decubal and Eucerin border between beauty care and medicated skin care by offering some products with active ingredients and others without. Busy consumers will be attracted to products with easy to use applicators and new formats. Marketing brands to adequately communicate product benefits will be a key success factor.

CATEGORY DATA

  • Table 69 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 70 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 71 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 72 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 73 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 74 Acne Treatments Brand Shares by Value 2007-2010
  • Table 75 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 76 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 77 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Norway - Category Analysis

HEADLINES

TRENDS

  • Norwegian health authorities continue to implement new initiatives to motivate Norwegians to stop smoking. Any disincentive to smoke is also an incentive for smokers to use NRT smoking cessation products to help them quit. The latest initiative is a ban on visible displays of tobacco and related products in retail outlets effective 1 January 2010. The objective is to eliminate any possibility of in-store advertising and decrease product awareness by removing the products from sight in retail outlets including grocery stores, gas stations, convenience stores, tax free stores, bars and restaurants and non-traditional points of sale such as concerts, festivals and exhibitions. The ban makes it more convenient for Norwegians to purchase NRT products than tobacco.

SWITCHES

COMPETITIVE LANDSCAPE

  • Two multinationals, McNeil and Novartis, are evenly matched competitors in NRT smoking cessation aids; each holding a value share of approximately 50%. McNeil produces and markets the Nicorette brands of chewing gum, inhalators, micro tabs and patches through its Pfizer division. The Nicotinell brand from Novartis is the only OTC NRT smoking cessation aid to compete with Nicorette. Nicotinell has a slightly different product range that includes chewing gum, patches and lozenges.

PROSPECTS

  • The Norwegian government is expected to continue to lead initiatives to stop smoking but it will be difficult to use these measures to convince the current group of dedicated smokers to stop. Today’s smokers need different arguments to convince them to stop. Once convinced, they need help from products such as NRT smoking cessation aids. However, these initiatives are predicted to discourage Norwegians from starting to smoke. The group of smokers who remain in Norway are dedicated and addicted to their tobacco products. Many of them have probably tried to quit many times and ultimately given up. This group will remain potential customers for NRT smoking cessation aids, even if they are not seeking to quit smoking but only cut down under special circumstances.

CATEGORY INDICATORS

  • Table 78 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 79 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 80 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 81 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 82 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 83 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 84 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 85 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Norway - Category Analysis

HEADLINES

TRENDS

  • In 2010, sports nutrition expanded its target segments to include the occasional athlete, i.e. people who work out once in a while, with the introduction of Tine BA’s YT series of sports nutrition products in the grocery channel. Sports nutrition products, such L-canintine and creatine powders, which are unfamiliar to the occasional athletes can often appear irrelevant as they are more interested in a nutritious snacks than optimal performance. A series of more familiar products supported by prestigious sports nutritionists helped to close the gap between nutrition for the sports enthusiast and the occasional athlete.

COMPETITIVE LANDSCAPE

  • Maxim Norge Nutrition AS, a subsidiary of Axellus AS, ranks as the leading supplier of sports nutrition products holdig a 43% value share. The company distributes products primarily through sportings goods channels and gyms to sports enthusiasts although it is expanding distribution to include universities and smaller grocery channels. The Maxim product line is more representative of traditional sports nutrition and includes creatine, energy and protein bars, protein powders and energy drinks. Maxim adds value to its brand by creating a brand extension for women called Femiline.

PROSPECTS

  • A wider audience is predicted to become regular consumers of mainstream sports nutrition products during the forecast period. Acceptance of these products as mainstream and as no longer simply products for just hard core body builders, is contributing to an increase in the number of non-typical consumers using the products, including women. The emergence of sports nutrition lines from brands which may already be well known to consumers may be another tactic to attract new consumers.

CATEGORY DATA

  • Table 86 Sales of Sports Nutrition: Value 2005-2010
  • Table 87 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 88 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 89 Sports Nutrition Company Shares 2006-2010
  • Table 90 Sports Nutrition Brand Shares 2007-2010
  • Table 91 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 92 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Table 93 Sports Nutrition Category Rankings 2010

Vitamins and Dietary Supplements in Norway - Category Analysis

HEADLINES

TRENDS

  • Cod liver oil and its most recent form, omega-3 tablets, are the two most popular products among the current selection of vitamins and dietary supplements in Norway. Norwegian doctors recommend consumption for all Norwegians, even infants from four weeks. The products contain all the dietary supplements inhabitants of Norway need: Omega-3 from fish oil and vitamins A, D, and E. Cod liver oil, the original source of omega-3, helps to improve the heart, blood circulation, immune system and concentration for all age groups. In spite of its unappealing taste, generations of Norwegians consume it daily.

Vitamins

Dietary Supplements

COMPETITIVE LANDSCAPE

  • Axellus, an Orkla Group subsidiary, leads dietary supplements with a value share of 17%. The company was formed in 2007 when Orkla Group merged three of Scandinavia’s leading players in vitamins and dietary supplements, Peter Möller AS, Collett Pharma AS and Danske Droge AS, into one entity. Since the merger, Axellus has focused on developing high-volume brands in both herbal/traditional and non-herbal/traditional dietary supplements for distribution primarily through grocery retailers, the traditional channel for Orkla brands. Cod liver oil and omega-3-6-9 are core products for Axellus that account for over 80% of its turnover in dietary supplements. Axellus leads both fish oils and omega-3-6-9 through the Möller's brand which holds a value share of 11% of the overall vitamins and dietary supplements category.

PROSPECTS

  • Omega-3-related innovation will be in focus during the forecast period. A new global Omega-3 Innovation Centre has just been established in Norway by a group called Nofima. The centre intends to work with issues such as the new research findings announced in 2010 aligning omega-3 with the prevention of cardiovascular diseases and other diseases such as cancer and osteoporosis. The level of expertise combined with interest is likely to bring forward a range of new applications for omega-3.

CATEGORY DATA

  • Table 94 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 96 Dietary Supplements by Positioning 2005-2010
  • Table 97 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 98 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 99 Vitamins Brand Shares by Value 2007-2010
  • Table 100 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 21 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in Norway - Category Analysis

HEADLINES

TRENDS

  • Problems with being overweight will not just go away, even in a country like Norway where inhabitants are active and fit compared to their western neighbours. Surveys conducted in 2009 show one in four adult Norwegians is overweight and there is a tendency for a higher percentage of Norwegian children and teenagers to be overweight. This trend is turning into a socioeconomic problem where the incidence of obesity and being overweight is twice as common in less affluent areas such as northern Norway and east Oslo compared to west Oslo. Research from the Norwegian Department of Public Health shows 14% of boys and 17% of girls are either overweight or obese in the 8-9-year-old age group. (Source: FHI “Barns vekst I Norge 2008). The problem of overweight and obesity among children increases the risk for overweight and obesity for adults which in turn creates a bigger risk for type 2 diabetes, high blood pressure, social difficulties, lung and sleeping problems which has a negative impact on the cost of administration of Norway’s public health service. The problem is serious enough for public health authorities to consider reinstating the practice of weighing school children. Health authorities are working on developing new public health initiatives to trim the expanding waistlines of Norway’s population of all ages.

COMPETITIVE LANDSCAPE

  • The competitive environment for weight management is characterised by diversity and fragmentation. Four companies, Herbalife, GlaxoSmithKline, Axellus and Med-Eq lead weight management with respective value shares of 21%, 15%, 13% and 12%. The remaining value share is apportioned among many smaller players, often with portfolios of only a few products. Both Axellus and Med-Eq are Norwegian companies working with domestically developed products.

PROSPECTS

  • The Norwegian Department of Public Health has clearly documented a trend that has developed over the past 20 years towards a higher incidence of overweight people. In spite of public health initiatives, it will be difficult to alter this trend within the relatively short time framework from 2010 to 2015. Norwegians are expected to continue their current patterns of weight management, i.e. New Year’s resolution to focus on weight loss after Christmas and before summer vacation.

CATEGORY DATA

  • Table 103 Sales of Weight Management: Value 2005-2010
  • Table 104 Sales of Weight Management: % Value Growth 2005-2010
  • Table 105 Weight Management Company Shares 2006-2010
  • Table 106 Weight Management Brand Shares 2007-2010
  • Table 107 Forecast Sales of Weight Management: Value 2010-2015
  • Table 108 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Norway - Category Analysis

HEADLINES

TRENDS

  • In 2010, the bestselling wound care products offer Norwegian consumers convenience in terms of healing properties, kits and appearance. First, recent launches of sticking plasters in 2010 such as Nexcare gelstrip finger contain hydrocolloid to promote healing. Brand leaders such as Johnson & Johnson, Actavis Nordic, Cederroth and Beiersdorf have introduced sticking plasters containing hydrocolloid. Second, pre-packaged first aid kits help consumers find the appropriate products for a variety of situations including burns, sports mishaps and car trips. Third, plasters can be applied in various formats such as Nexcare Spray Plaster and Compeed blister stick. The new applications facilitate application and diminish pain during wound care. With the varied product selection of Norwegian retailers, consumers no longer need to settle for textile sticking plasters that fall off quickly.

COMPETITIVE LANDSCAPE

  • Actavis Nordic leads wound care with a 42% share of value through the success of its Norgesplaster brands of sticking plaster and other wound care treatments for both adults and children. Founded in 1937, Norgesplaster is a well-established brand, present in the medicine cabinets of most Norwegian households. The company is the only domestic producer of wound care products.

PROSPECTS

  • Wound care is expected to make a greater contribution to healing than just covering the sore. The bestsellers during the forecast period are likely to offer consumers benefits in terms of healing faster, removing pain, disinfecting the wound and making the wounded area appear more attractive. Suppliers will be able to launch more complex wound treatment products that can be easily explained to consumers via websites or by pharmacy staff.

CATEGORY DATA

  • Table 109 Sales of Wound Care by Category: Value 2005-2010
  • Table 110 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 111 Wound Care Company Shares by Value 2006-2010
  • Table 112 Wound Care Brand Shares by Value 2007-2010
  • Table 113 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 114 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Blueberry
            • Cranberry
            • Isoflavones
            • Roseroot
            • Soya
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Child-Specific Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Child-Specific Consumer Health
        • Child-Specific Analgesics
          • Child-Specific Acetaminophen
          • Child-Specific Aspirin
          • Child-Specific Combination Products - Analgesics
          • Child-Specific Diclofenac
          • Child-Specific Dipyrone
          • Child-Specific Ibuprofen
          • Child-Specific Ketoprofen
          • Child-Specific Naproxen
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Child-Specific Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Child-Specific Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market sizes
    • Company shares
    • Brand shares
    • Distribution
    • Analysis by format
    • Analysis by positioning
    • Analysis by type
    • Herbal/traditional vs standard
    • Pricing
    • Smoking incidence

    Market size details:

    • Retail volume
    • Retail volume % growth
    • Retail volume per capita
    • Retail value retail selling price % growth
    • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices % growth
    • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price % growth
    • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices % growth
    • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices % growth
    • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices % growth
    • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

    RELATED

    Country Report

    Consumer Lifestyle

    Future Demographic

    Country Report